Related Experiment Videos
Candidate reference methods for hemoglobin A1c based on peptide mapping
U Kobold1, J O Jeppsson, T Dülffer
1Boehringer Mannheim GmbH Lab Diagnostics, Research Center Tutzing, Germany. uwevkobold@bmg.boehringer-mannheim.com
Clinical Chemistry
|October 28, 1997
Summary
A new method precisely quantifies hemoglobin A1c (HbA1c) by analyzing specific peptide fragments. This advancement improves the international standardization of HbA1c measurements for better diabetes management.
Area of Science:
- Clinical Chemistry
- Analytical Chemistry
- Biochemistry
Background:
- Accurate hemoglobin A1c (HbA1c) measurement is crucial for diabetes monitoring and international standardization.
- Current methods face limitations in resolving HbA1c from other hemoglobin variants.
Purpose of the Study:
- To develop and validate a novel reference method for specific HbA1c quantification.
- To enhance the precision and reliability of HbA1c measurements for global standardization.
Main Methods:
- Optimized enzymatic cleavage of hemoglobin using endoproteinase Glu-C to isolate specific beta-N-terminal hexapeptides of HbA1c and HbA0.
- Separation of peptides via reversed-phase high-performance liquid chromatography (RP-HPLC).
- Quantification using either electrospray ionization-mass spectrometry (ESI-MS) or capillary electrophoresis (CE).
Main Results:
- Successfully isolated and quantified specific HbA1c and HbA0 peptides.
- Achieved superior resolution of HbA1c compared to existing protein separation systems.
- Demonstrated the feasibility of the developed method for accurate HbA1c measurement.
Conclusions:
- The novel peptide-based method offers improved specificity and resolution for HbA1c quantification.
- This technique provides a robust foundation for the international standardization of HbA1c reference systems.
- The method holds potential for more accurate clinical assessment of glycemic control.